These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15324818)

  • 1. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells.
    Chiu YL; Ali A; Chu CY; Cao H; Rana TM
    Chem Biol; 2004 Aug; 11(8):1165-75. PubMed ID: 15324818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells.
    Arthanari Y; Pluen A; Rajendran R; Aojula H; Demonacos C
    J Control Release; 2010 Aug; 145(3):272-80. PubMed ID: 20403398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
    Yoo JW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting RNA-interference pathway with small molecules.
    Chiu YL; Dinesh CU; Chu CY; Ali A; Brown KM; Cao H; Rana TM
    Chem Biol; 2005 Jun; 12(6):643-8. PubMed ID: 15975509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric RNA duplexes mediate RNA interference in mammalian cells.
    Sun X; Rogoff HA; Li CJ
    Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on RNAi of the tight structure, sequence and position of the targeted region.
    Yoshinari K; Miyagishi M; Taira K
    Nucleic Acids Res; 2004; 32(2):691-9. PubMed ID: 14762201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins.
    Boden D; Pusch O; Silbermann R; Lee F; Tucker L; Ramratnam B
    Nucleic Acids Res; 2004; 32(3):1154-8. PubMed ID: 14966264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The six amino acid antimicrobial peptide bLFcin6 penetrates cells and delivers siRNA.
    Fang B; Guo HY; Zhang M; Jiang L; Ren FZ
    FEBS J; 2013 Feb; 280(4):1007-17. PubMed ID: 23241223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structure, and biological activity of dumbbell-shaped nanocircular RNAs for RNA interference.
    Abe N; Abe H; Nagai C; Harada M; Hatakeyama H; Harashima H; Ohshiro T; Nishihara M; Furukawa K; Maeda M; Tsuneda S; Ito Y
    Bioconjug Chem; 2011 Oct; 22(10):2082-92. PubMed ID: 21899349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Great potential of small RNAs: RNA interference and microRNA].
    Vázquez-Ortiz G; Piña-Sánchez P; Salcedo M
    Rev Invest Clin; 2006; 58(4):335-49. PubMed ID: 17146945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular siRNA delivery mediated by a cell-permeant RNA-binding protein and photoinduced RNA interference.
    Endoh T; Sisido M; Ohtsuki T
    Bioconjug Chem; 2008 May; 19(5):1017-24. PubMed ID: 18442282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1-specific RNA interference.
    Boden D; Pusch O; Ramratnam B
    Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of assembly of siRNA elements into RNA-induced silencing complex by fork-siRNA duplex carrying nucleotide mismatches at the 3'- or 5'-end of the sense-stranded siRNA element.
    Ohnishi Y; Tokunaga K; Hohjoh H
    Biochem Biophys Res Commun; 2005 Apr; 329(2):516-21. PubMed ID: 15737617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular siRNA delivery using TatU1A and photo-induced RNA interference.
    Endoh T; Ohtsuki T
    Methods Mol Biol; 2010; 623():271-81. PubMed ID: 20217557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively.
    Fang B; Jiang L; Zhang M; Ren FZ
    Biochimie; 2013 Feb; 95(2):251-7. PubMed ID: 23009929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intracellular delivery method for siRNA by an arginine-rich peptide.
    Wang YH; Hou YW; Lee HJ
    J Biochem Biophys Methods; 2007 Jun; 70(4):579-86. PubMed ID: 17320189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular siRNA and precursor miRNA trafficking using bioresponsive copolypeptides.
    Rahbek UL; Howard KA; Oupicky D; Manickam DS; Dong M; Nielsen AF; Hansen TB; Besenbacher F; Kjems J
    J Gene Med; 2008 Jan; 10(1):81-93. PubMed ID: 18000993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.